| Cat. No. | Product Name | Information | 
            
                
            	| PC-24644 | BBO-10203 RAS-PI3Kα inhibitor | BBO-10203 is a first-in-class inhibitor of the RAS-PI3Kα interaction, binds specifically and cocalently to the RBD of PI3Kα (IC50=3 nM), disrupts PI3Kα interaction with K-,H-, and N-RAS with low single digit nanomolar potency (5 nM). | 
            
                
            	| PC-23222 | CHF-6523 PI3Kδ inhibitor | CHF-6523 is a potent, selective and inhaled PI3Kδ inhibitor with enzymatic pKi value of 9.07 and pIC50 of 8.78 in THP-1 assay. | 
            
                
            	| PC-23166 | Linperlisib PI3Kδ inhibitor | Linperlisib (YY-20394) is a potent, selective and orally active PI3Kδ inhibitor (IC50=4.6 nM), inhibits PI3Kδ expressing human tumor cells growth both in vitro and in vivo. | 
            
                
            	| PC-23002 | PITCOIN4 PI3K-C2α inhibitor | PITCOIN4 is a potent, highly selective inhibitor of class II alpha PI3K (PI3K-C2α) with IC50 of 56 nM, >100-fold selectivity over PI3K-C2β. | 
            
                
            	| PC-22488 | Taselisib PI3Kα inhibitor | Taselisib (GDC-0032, RG-7604) is a potent, selective inhibitor of PIK3CA (PI3Kα) with Ki of 0.29 nM and pAkt IC50 of 4 nM, 31-fold selective over PI3Kβ. | 
            
                
            	| PC-22458 | AS-252424 PI3Kγ inhibitor | AS-252424 is a potent, and selective inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ) with IC50 of 30 nM, 30-fold selective over PI3Kα, also is a potent ferroptosis inhibitor targeting ACSL4. | 
            
                
            	| PC-22175 | KTC1101 pan-PI3K inhibitor | KTC1101 is a potent, selective pan-PI3K inhibitor with IC50 of 3.72 nM for PI3Kα, 36.29 nM for PI3Kβ, 1.22 nM for PI3Kδ, and 17.09 nM for PI3Kγ. | 
            
                
            	| PC-21944 | GSK2636771 PI3Kβ inhibitor | GSK2636771 is a potent, selective and orally bioavailable inhibitor of PI3Kβ with Ki/IC50 of 0.89/5.2 nM, respectively. | 
            
                
            	| PC-21298 | RLY-2608 PI3Kα H1047R inhibitor | RLY-2608 (Zovegalisib, RLY2608) is a first-in-class, allosteric, mutant-selective inhibitor of PI3Kα with IC50 of 4 nM (PI3Kα H1047R), 12-fold selective over PI3Kα WT. | 
            
                
            	| PC-21139 | STX-478 PI3Kα H1047R inhibitor | Tersolisib (STX-478, STX478) is a potent, mutant-selective, allosteric PI3Kα inhibitor with IC50 of 9.4 nM (PI3Kα H1047R), 14-fold selectivity over WT PI3Kα (IC50=131 nM). | 
            
                
            	| PC-20848 | UCL-TRO-1938 PI3Kα activator | UCL-TRO-1938 (Compound 1938) is a selective, allosteric activator of PI3Kα with EC50 of 60 uM (based on in vitro lipid kinase activity), directly activates PI3Kα signalling in cells. | 
            
                
            	| PC-20591 | IOA-244 PI3Kδ inhibitor | IOA-244 (Roginolisib, MSC2360844) is a potent, selective and non-ATP-competitive PI3Kδ inhibitor with IC50 of 19 nM, selective over PI3Kβ (0.43 uM), Vps34 (9 uM) and PI3Kα (10.1 uM). |